Syneron Bio Raises $150 Million in Series B Financing to Enhance Drug Discovery Platform Syneron Bio has successfully completed $150 million in Series B financing to boost its macrocyclic peptide drug development efforts and clinical pipeline enhancements.

Syneron Bio Raises $150 Million in Series B Financing to Enhance Drug Discovery Platform #China #Beijing #Syneron_Bio #Synova #macrocyclic_peptides